Biomarker Assay Development, Qualification, and Validation

Guang Chen (), Shuguang Huang, Winnie Weng and Cheng Su
Additional contact information
Guang Chen: Gilead Sciences Inc.
Shuguang Huang: Stat4ward LLC
Winnie Weng: Gilead Sciences Inc.
Cheng Su: BioMarin Pharmaceutical Inc.

A chapter in Statistical Methods in Biomarker and Early Clinical Development, 2019, pp 87-115 from Springer

Abstract: Abstract Biomarker is defined as a characteristic that is objectively measured and evaluated as an indicator of biological processes. A bioanalytical method that can accurately and reproducibly measure such characteristic is essential for the success of biomarker application. Biomarker assay development and validation is an important component of biomarker development and qualification. The objective of this chapter is to introduce the processes of assay development and validation, the key analytical parameters of an assay that need to be evaluated, and the statistical consideration and methodology commonly used in study design and data analysis.

Date: 2019
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-030-31503-0_6

Ordering information: This item can be ordered from
http://www.springer.com/9783030315030

DOI: 10.1007/978-3-030-31503-0_6

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().